COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR PARENTERAL ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY

Composition comprises at least one omega -3 fatty acid of eicosapentaenoic (EPA) acid and/or docosahexaenoic acid (DHA), for improving the efficacy of chemotherapy or radiotherapy and/or in the prevention or reduction of the chemotherapy or radiotherapy-induced side effects in a patient suffering fr...

Full description

Saved in:
Bibliographic Details
Main Authors KRAMPITZ, BARBARA, SCHLOTZER, EWALD, SUCHNER, ULRICH
Format Patent
LanguageEnglish
Polish
Published 28.09.2018
Subjects
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:Composition comprises at least one omega -3 fatty acid of eicosapentaenoic (EPA) acid and/or docosahexaenoic acid (DHA), for improving the efficacy of chemotherapy or radiotherapy and/or in the prevention or reduction of the chemotherapy or radiotherapy-induced side effects in a patient suffering from cancer. The composition is administered to the patient before initiating a cycle of chemotherapy or radiotherapy. ACTIVITY : Cytostatic; Gastrointestinal-Gen; Antianemic; Hepatotropic; CNS-Gen; Cardiant; Antiinflammatory; Immunostimulant. MECHANISM OF ACTION : None given.
Bibliography:Application Number: PL20110746585T